首页> 外文期刊>OncoTargets and therapy >Identifying an Eight-Gene Signature to Optimize Overall Survival Prediction of Esophageal Adenocarcinoma Using Bioinformatics Analysis of ceRNA Network
【24h】

Identifying an Eight-Gene Signature to Optimize Overall Survival Prediction of Esophageal Adenocarcinoma Using Bioinformatics Analysis of ceRNA Network

机译:使用Cerna网络的生物信息分析来确定八基因签名以优化食管腺癌的总体存活预测

获取原文
获取外文期刊封面目录资料

摘要

Background and Aims:Esophageal adenocarcinoma (EAC) patients usually have a poor prognosis without early diagnosis. In this study, we aimed to identify a novel signature to improve the prediction of overall survival (OS) in EAC.Methods:Eighty-one and 68 samples from The Cancer Genome Atlas (TCGA) and GSE19417 dataset were included for discovery and survival validation, respectively. In the TCGA cohort, a total of 1,811 DEmRNAs, 1,096 DElncRNAs, and 31 DEmiRNAs were identified between EAC and normal esophagus tissues. A mRNA-miRNA-lncRNA ceRNA network of EAC was established, which consisted of 94 DEmRNAs, 13 DEmiRNAs, and 46 DElncRNAs.Results:In this study, we identified eight genes (UBE2B, LAMP2, B3GNT2, TAF9B, EFNA1, PHF8, PIGA, and NEURL1) which were related to survival in EAC. The independent external microarray data from the Gene Expression Omnibus (GEO) was used to validate these candidate genes. The prognostic ability of the signature was also validated in EAC patients in our hospital. Patients assigned to the high-risk group had a poor overall survival rate compared with the low-risk.Conclusion:The current study provides novel insights into the mRNA-related ceRNA network in EAC and the eight mRNA biomarkers may be independent prognostic signatures in predicting the survival of EAC patients.? 2020 Wang et al.
机译:背景和目的:食管腺癌(EAC)患者通常具有较差的预后没有早期诊断。在这项研究中,我们旨在确定一种新的签名,以改善EAC中的整体存活(OS)预测的内容:来自癌症基因组阿特拉斯(TCGA)和GSE19417数据集的八十一和68个样本被纳入发现和生存验证, 分别。在TCGA队列中,在EAC和正常食道组织之间鉴定了总共1,811个DEMRNA,1,096次DELNCRNA和31个DemiRNA。建立了EAC的mRNA-miRNA-lncrna Cerna网络,其中包括94个Demrnas,13 demiRNA和46 delncrnas.results:在本研究中,我们确定了八个基因(Ube2b,灯2,b3gnt2,taf9b,efna1,phf8,piga和Neurl1)与EAC中生存有关。来自基因表达综合血症(Geo)的独立外部微阵列数据用于验证这些候选基因。签名的预后能力也在我们医院的EAC患者中验证。分配给高风险组的患者与低风险相比,整体存活率差。结论:目前的研究为EAC中的MRNA相关的Cerna网络提供了新的洞察力,八个mRNA生物标志物可能是独立预测的独立预后签名EAC患者的存活率。? 2020 Wang等人。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号